BRIEF-India's Alembic Receives USFDA Approvals For Deferasirox Tablets - Reuters
22-Nov-2019 12:48:46 PM
Nov 22 (Reuters) - Alembic Pharmaceuticals Ltd ALEM.NS:
RECEIVES USFDA APPROVALS
RECEIVES FINAL USFDA APPROVALS FOR DEFERASIROX TABLETS 90, 360 MG AND DEFERASIROX TABLETS FOR ORAL SUSPENSION, 125, 250 MG
RECEIVES TENTATIVE USFDA APPROVALS FOR DEFERASIROX TABLETS, 180 MG